From: Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation
Variables | AF patients (n = 706) | Controls (n = 661) | P | |
---|---|---|---|---|
Baseline characteristics, n (%) | Â | Â | Â | |
Age ≥ 65y | 575(81.44) | 396(59.91) | < 0.001 | |
Male | 414(58.64) | 393(59.46) | 0.783 | |
SBP ≥ 140mm Hg | 329(46.60) | 307(46.44) | 0.954 | |
DBP ≥ 90mm Hg | 242(34.28) | 173(26.17) | < 0.001 | |
APOE-ε4 carrier | 226(32.01) | 180(27.23) | 0.053 | |
Alcohol intake | Â | Â | Â | |
Never | 677(95.89) | 630(95.31) | 0.175 | |
Former | 15(2.12) | 9(1.36) | ||
Current | 14(1.98) | 22(3.33) | ||
Smoking status | Â | Â | Â | |
Never | 542(76.77) | 498(75.34) | 0.101 | |
Former | 89(12.61) | 70(10.59) | ||
Current | 75(10.62) | 93(14.07) | ||
Medical history, n (%) | Â | Â | Â | |
Hypertension | 424(60.06) | 379(57.34) | 0.307 | |
Diabetes | 206(29.18) | 188(28.44) | 0.764 | |
CAD | 390(55.24) | 223(33.74) | < 0.001 | |
HF | 294(41.64) | 63(9.53) | < 0.001 | |
Drug Therapy, n (%) | Â | Â | Â | |
Statin | 16(2.27) | 12(1.82) | 0.556 | |
ACEIs | 190(26.91) | 111(16.79) | < 0.001 | |
ARBs | 148(20.96) | 149(22.54) | 0.479 | |
BBs | 302(42.78) | 179(27.08) | < 0.001 | |
MRAs | 275(38.95) | 53(8.02) | < 0.001 | |
Digoxin | 197(27.90) | 24(3.63) | < 0.001 | |
Diuretics | 324(45.89) | 91(13.77) | < 0.001 |